Depression, comorbidities, and prescriptions of antidepressants in a German Network of GPs and specialists with subspecialisation in anthroposophic medicine: A longitudinal observational study

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Jeschke, Elke ^a   Ostermann, Thomas ^b   Vollmar, Horst C ^c   Tabali, Manuela ^a   Matthes, Harald ^a,b  

^a Havelhoehe Research Institute   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; HYPERICUM PERFORATUM EXTRACT;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; COMORBIDITY; DEPRESSION; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERICUM PERFORATUM; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL;

EID: 84871368108     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/508623     Document Type: Article

References (31)

1. Moussavi S., Chatterji S., Verdes E., Tandon A., Patel V., Ustun B., Depression, chronic diseases, and decrements in health: results from the World Health Surveys. The Lancet 2007 370 9590 851 858 2-s2.0-34548396844 10.1016/S0140-6736(07)61415-9 (Pubitemid 47362344)
2. World Health Organisation, Mental health, new understanding, new hope. World Health Report 2001 2001 Geneva, Switzerland WHO. http://www.who.int/whr/ 2001/en/whr01-en.pdf
3. Bramesfeld A., Grobe T., Schwartz F. W., Prevalence of depression diagnosis and prescription of antidepressants in East and West Germany: an analysis of health insurance data. Social Psychiatry and Psychiatric Epidemiology 2010 45 3 329 335 2-s2.0-77949385579 10.1007/s00127-009-0067-8
4. Ornstein S., Stuart G., Jenkins R., Depression diagnoses and antidepressant use in primary care practices: a study from the practice partner research network (PPRNet). Journal of Family Practice 2000 49 1 68 72 2-s2.0-0033915111 (Pubitemid 30489238)
5. Bramesfeld A., Grobe T. G., Schwartz F. W., Who is diagnosed as suffering from depression in the German statutory health care system? An analysis of health insurance data. European Journal of Epidemiology 2007 22 6 397 403 2-s2.0-34447339095 10.1007/s10654-007-9128-z (Pubitemid 47052080)
6. DGPPN, BÄK, KBV, AWMF, AkdÄ BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW, für die Leitliniengruppe Unipolare Depression. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression-Langfassung 2009 1st Berlin, Germany DGPPN, ÄZQ, AWMF. http://www.dgppn.de/ http://www.versorgungsleitlinien.de/ http://awmf-leitlinien.de/
7. Wittchen H. U., Höfler M., Meister W., Prevalence and recognition of depressive syndromes in german primary care settings: poorly recognized and treated? International Clinical Psychopharmacology 2001 16 3 121 135 2-s2.0-0035030041 (Pubitemid 32402357)
8. Härter M., Bermejo I., Ollenschläger G., Schneider F., Gaebel W., Hegerl U., Niebling W., Berger M., Improving quality of care for depression: The German Action Programme for the implementation of evidence-based guidelines. International Journal for Quality in Health Care 2006 18 2 113 119 2-s2.0-33645544361 10.1093/intqhc/mzi089
9. Härter M., Klesse C., Bermejo I., Bschor T., Gensichen J., Harfst T., Hautzinger M., Kolada C., Kopp I., Kühner C., Lelgemann M., Matzat J., Meyerrose B., Mundt C., Niebling W., Ollenschläger G., Richter R., Schauenburg H., Schulz H., Weinbrenner S., Schneider F., Berger M., Evidence-based therapy of depression. S3 guidelines on unipolar depression. Nervenarzt 2010 81 9 1049 1068 2-s2.0-77957773760 10.1007/s00115-010-3084-7
10. Holsboer-Trachsler E., Hättenschwiler J., Beck J., Brand S., Hemmeter U. M., Keck M. E., Rennhard S., Hatzinger M., Merlo M., Bondolfi G., Preisig M., Andreoli Y. A., Bielinski D., Seifritz E., Die somatische Behandlung der unipolaren depressiven Störungen. Schweiz Med Forum 2010 10 802 809
11. Ravindran A. V., Lam R. W., Filteau M. J., Lespérance F., Kennedy S. H., Parikh S. V., Patten S. B., Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. Journal of Affective Disorders 2009 117 1 S54 S64 2-s2.0-69749084154 10.1016/j.jad.2009.06.040
12. Kasper S., Caraci F., Forti B., Drago F., Aguglia E., Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression. European Neuropsychopharmacology 2010 20 11 747 765 2-s2.0-77957018511 10.1016/j.euroneuro.2010.07.005
13. Linde K., Berner M. M., Kriston L., St John's wort for major depression. Cochrane Database of Systematic Reviews 2008 4, article CD000448 2-s2.0-58249090126
14. Dwyer A. V., Whitten D. L., Hawrelak J. A., Herbal medicines, other than St. John's Wort, in the treatment of depression: a systematic review. Alternative Medicine Review 2011 16 1 40 49 2-s2.0-79955667458
15. Davidson J. R. T., Crawford C., Ives J. A., Jonas W. B., Homeopathic treatments in psychiatry: a systematic review of randomized placebo-controlled studies. Journal of Clinical Psychiatry 2011 72 6 795 805 2-s2.0-79959620424 10.4088/JCP.10r06580
16. Jeschke E., Ostermann T., Tabali M., Bockelbrink A., Witt C. M., Willich S. N., Matthes H., Diagnostic profiles and prescribing patterns in everyday anthroposophic medical practice-a prospective multi-centre study. Forschende Komplementarmedizin 2009 16 5 325 333 2-s2.0-70449381828 10.1159/000235239
17. Tabali M., Jeschke E., Witt C. M., Ostermann T., Matthes H., Adverse drug reactions for CAM and Conventional drugs detected in a network of Physicians Certified to prescribe CAM drugs. Journal of Managed Care Pharmacy 2012 18 6 427 438
18. Arbeitsgruppe Erhebung und Nutzung von Sekundärdaten der Deutschen Gesellschaft für Sozialmedizin und Prävention, Arbeitsgruppe Epidemiologische Methoden der Deutschen Gesellschaft für Epidemiologie, Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie, Deutschen Gesellschaft für Sozialmedizin und Prävention, Good practice of secondary data analysis, first revision. Gesundheitswesen 2008 701 54 60
19. Jeschke E., Schad F., Pissarek J., Matthes B., Albrecht U., Matthes H., QuaDoSta-ein frei konfigurierbares System zur Unterstützung multizentrischer Datenerhebungen in medizinischer Versorgung und Forschung. GMS Medizinische Informatik, Biometrie Und Epidemiologie 2007 3 10
20. Kassenärztliche Bundesvereinigung (KBV), Grunddaten zur Vertragsärztlichen Versorgung in Deutschland 2011. http://www.kbv.de/ publikationen/125.html
21. Gill J. M., Ying X. C., Lieberman M. I., Management of depression in ambulatory care for patients with medical co-morbidities: a study from a national electronic health record (EHR) network. International Journal of Psychiatry in Medicine 2008 38 2 203 215 2-s2.0-57749199137 10.2190/PM.38.2.g
22. Gill J. M., Klinkman M. S., Chen Y. X., Antidepressant medication use for primary care patients with and without medical comorbidities: a national Electronic Health Record (EHR) network study. Journal of the American Board of Family Medicine 2010 23 4 499 508 2-s2.0-77955300664 10.3122/jabfm.2010.04. 090299
23. Robinson W. D., Geske J. A., Prest L. A., Barnacle R., Depression treatment in primary care. Journal of the American Board of Family Practice 2005 18 2 79 86 2-s2.0-23044507756 (Pubitemid 41664011)
24. Sieberer M., Glaeske G., Schicktanz C., Auswertungsergebnisse der BARMER GEK Arzneimitteldaten aus den Jahren 2008 und 2009. BARMER GEK Arzneimittel-Report 2010 2010 2 Schriftenreihe zur Gesundheitsanalyse 137 149
25. Grobe T., Dörning H., Gesundheits report 2010- Veröffentlichungen zum Betrieblichen Gesundheitsmanagement der TK 24 Hamburg, Germany Techniker Krankenkasse. http://www.tk-online.de/
26. Moncrieff J., Cohen D., Do antidepressants cure or create abnormal brain states? PLoS Medicine 2006 3 7, article e240 2-s2.0-33746416661 10.1371/journal.pmed.0030240 (Pubitemid 44125974)
27. Kirsch I., Deacon B. J., Huedo-Medina T. B., Scoboria A., Moore T. J., Johnson B. T., Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Medicine 2008 5 2, article e45 2-s2.0-39849093340 10.1371/journal.pmed.0050045 (Pubitemid 351317657)
28. Katon W., Sullivan M. D., Depression and chronic medical illness. Journal of Clinical Psychiatry 1990 51 1 3 11 2-s2.0-0025367995 (Pubitemid 20212857)
29. Jacobi F., Wittchen H. U., Hölting C., Höfler M., Pfister H., Müller N., Lieb R., Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychological Medicine 2004 34 4 597 611 2-s2.0-2342554541 10.1017/S0033291703001399 (Pubitemid 38735455)
30. World Health Organization (WHO), Wellbeing Measures in Primary Health Care: The DepCare Project 1998 Copenhagen, Denmark WHO
31. Spitzer R. L., Kroenke K., Williams J. B. W., Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. Journal of the American Medical Association 1999 282 18 1737 1744 2-s2.0-0033544340 10.1001/jama.282.18.1737 (Pubitemid 29533604)